Details
Stereochemistry | RACEMIC |
Molecular Formula | C23H18Cl3FN4O3S |
Molecular Weight | 555.836 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[O-][N+](=O)C1=C(F)C=CC(NC(=S)NC(NC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3)C(Cl)(Cl)Cl)=C1
InChI
InChIKey=HLCDNLNLQNYZTK-UHFFFAOYSA-N
InChI=1S/C23H18Cl3FN4O3S/c24-23(25,26)21(30-22(35)28-16-11-12-17(27)18(13-16)31(33)34)29-20(32)19(14-7-3-1-4-8-14)15-9-5-2-6-10-15/h1-13,19,21H,(H,29,32)(H2,28,30,35)
Molecular Formula | C23H18Cl3FN4O3S |
Molecular Weight | 555.836 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/16767085 | https://www.ncbi.nlm.nih.gov/pubmed/18560433Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/18347191 | https://www.ncbi.nlm.nih.gov/pubmed/19903334 | http://www.selleckchem.com/products/cgk-733.html | https://www.ncbi.nlm.nih.gov/pubmed/24795863 | https://www.ncbi.nlm.nih.gov/pubmed/21865098
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16767085 | https://www.ncbi.nlm.nih.gov/pubmed/18560433
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/18347191 | https://www.ncbi.nlm.nih.gov/pubmed/19903334 | http://www.selleckchem.com/products/cgk-733.html | https://www.ncbi.nlm.nih.gov/pubmed/24795863 | https://www.ncbi.nlm.nih.gov/pubmed/21865098
Diphenyl acetamidotrichloroethyl fluoronitrophenyl thiourea, CGK733, was claimed to be selective inhibitor of the ataxia telangiectasia-mutated (ATM) protein and ATM- and Rad3-related (ATR) protein, however after investigation of the contents of the original paper by Korean Advanced Institute of Science and Technology (KAIST) several irregularities has been revealed and the paper was retracted in full. Further studies were completed showing that CGK-733 has no specific inhibitory effect on ATM or ATR. Unfortunately, the compound is still being marketed as an ATM/ATR inhibitor. CGK733 inhibits the proliferation of human cancer and non-transformed mouse fibroblast cell lines and induced senescent breast, lung, and colon carcinoma cells to undergo cell death.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16767085
Curator's Comment: Won et al, 2006
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0008283 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19903334 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Small molecule-based reversible reprogramming of cellular lifespan. | 2006 Jul |
|
Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: implications for chemotherapy. | 2008 Mar 15 |
|
The ATM and ATR inhibitors CGK733 and caffeine suppress cyclin D1 levels and inhibit cell proliferation. | 2009 Nov 10 |
|
CGK733 does not inhibit ATM or ATR kinase activity in H460 human lung cancer cells. | 2011 Oct 10 |
|
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. | 2011 Oct 30 |
|
CGK733 enhances multinucleated cell formation and cytotoxicity induced by taxol in Chk1-deficient HBV-positive hepatocellular carcinoma cells. | 2012 May 25 |
|
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. | 2013 Apr 15 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19903334
10 uM CGK733 inhibits cell proliferation in MCF-7, T47D and MDA-MB436 breast cancer cells, LNCaP prostate cancer cells, HCT116 colon cancer cells and BALB/c 3T3 fibroblasts
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:22:16 GMT 2023
by
admin
on
Sat Dec 16 10:22:16 GMT 2023
|
Record UNII |
L3DGZ99QYM
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
905973-89-9
Created by
admin on Sat Dec 16 10:22:16 GMT 2023 , Edited by admin on Sat Dec 16 10:22:16 GMT 2023
|
PRIMARY | |||
|
L3DGZ99QYM
Created by
admin on Sat Dec 16 10:22:16 GMT 2023 , Edited by admin on Sat Dec 16 10:22:16 GMT 2023
|
PRIMARY | |||
|
DTXSID30424997
Created by
admin on Sat Dec 16 10:22:16 GMT 2023 , Edited by admin on Sat Dec 16 10:22:16 GMT 2023
|
PRIMARY | |||
|
6605258
Created by
admin on Sat Dec 16 10:22:16 GMT 2023 , Edited by admin on Sat Dec 16 10:22:16 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |